Urinary Tract Infection (Staphylococcus saprophyticus)
Overview
Plain-Language Overview
Urinary Tract Infection (Staphylococcus saprophyticus) is an infection that affects the urinary system, which includes the kidneys, bladder, and urethra. This condition is caused by the bacteria Staphylococcus saprophyticus, which commonly infects the bladder and urethra. It mainly affects young, sexually active women and causes symptoms such as painful urination, frequent urge to urinate, and lower abdominal discomfort. The infection can lead to inflammation and irritation of the urinary tract lining. If untreated, it may progress to more serious infections involving the kidneys. Early recognition of symptoms is important for diagnosis and management.
Clinical Definition
Urinary Tract Infection (Staphylococcus saprophyticus) is a bacterial infection primarily involving the lower urinary tract, especially the bladder (cystitis). It is caused by the gram-positive, coagulase-negative bacterium Staphylococcus saprophyticus, which is a common cause of uncomplicated UTIs in young women. The pathogenesis involves bacterial adherence to uroepithelial cells via surface adhesins, leading to colonization and inflammation. Clinically, it presents with dysuria, urinary frequency, urgency, and suprapubic pain. Unlike Escherichia coli, S. saprophyticus is notable for its resistance to novobiocin, aiding in laboratory identification. The infection is significant due to its prevalence and potential to cause recurrent UTIs if not properly treated.
Inciting Event
Introduction of bacteria into the urethra during sexual intercourse is the most common trigger.
Disruption of normal vaginal or periurethral flora by spermicides or antibiotics.
Instrumentation of the urinary tract such as catheterization or cystoscopy.
Latency Period
Symptoms typically develop within 1 to 3 days after bacterial introduction.
Rapid onset of dysuria and urinary frequency following exposure.
Diagnostic Delay
Misattribution of symptoms to vaginal irritation or sexually transmitted infections can delay diagnosis.
Failure to perform urine culture or urinalysis may lead to missed identification of S. saprophyticus.
Assuming Escherichia coli as the sole cause of UTI without considering other pathogens.
Clinical Presentation
Signs & Symptoms
Dysuria (painful urination) is the hallmark symptom
Frequency and urgency of urination without significant volume
Suprapubic discomfort or lower abdominal pain
Hematuria may be present in some cases
Cloudy or foul-smelling urine
History of Present Illness
Acute onset of dysuria, urinary frequency, and urgency is typical.
Suprapubic discomfort or mild lower abdominal pain may be reported.
Absence of systemic symptoms such as fever distinguishes uncomplicated cystitis.
Symptoms often begin within days of sexual intercourse or other inciting events.
Past Medical History
Previous urinary tract infections increase susceptibility to recurrent infections.
Use of spermicides or diaphragms is relevant due to alteration of normal flora.
History of urinary tract instrumentation or catheterization predisposes to infection.
Family History
[]
Physical Exam Findings
Suprapubic tenderness on palpation indicating bladder inflammation
Costovertebral angle tenderness is typically absent in uncomplicated lower UTI
Normal vital signs unless systemic infection or pyelonephritis develops
No flank masses or palpable bladder unless severe urinary retention
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by the presence of urinary symptoms such as dysuria and frequency combined with a positive urinalysis showing pyuria and bacteriuria. Definitive diagnosis requires urine culture demonstrating growth of Staphylococcus saprophyticus at a concentration of ≥10^5 colony-forming units per milliliter. The organism's novobiocin resistance helps differentiate it from other coagulase-negative staphylococci. Imaging is generally not required unless complicated infection is suspected.
Pathophysiology
Key Mechanisms
Adherence of Staphylococcus saprophyticus to uroepithelial cells via surface adhesins facilitates colonization.
Urethral colonization leads to ascending infection of the urinary tract causing inflammation.
Biofilm formation on urinary tract mucosa enhances bacterial persistence and resistance to host defenses.
Host immune response triggers local inflammation resulting in symptoms such as dysuria and frequency.
| Involvement | Details |
|---|---|
| Organs | Bladder is the main organ affected in uncomplicated urinary tract infections, presenting with symptoms such as dysuria and urgency |
Urethra serves as the entry point for Staphylococcus saprophyticus and is involved in the initial colonization during infection | |
| Tissues | Urothelium is the specialized epithelial tissue lining the urinary tract that is the primary site of bacterial colonization and inflammation in urinary tract infections |
| Cells | Neutrophils are the primary immune cells that infiltrate the urinary tract to phagocytose and kill Staphylococcus saprophyticus during infection |
Urothelial cells line the urinary tract and act as a barrier; their disruption facilitates bacterial adherence and invasion | |
| Chemical Mediators | Interleukin-8 (IL-8) is released by infected urothelial cells to recruit neutrophils to the site of infection |
Tumor necrosis factor-alpha (TNF-α) promotes inflammation and helps coordinate the immune response against the bacterial pathogen |
Treatments
Pharmacological Treatments
Nitrofurantoin
- Mechanism:
Inhibits bacterial enzymes involved in DNA, RNA, and cell wall synthesis, effective against gram-positive cocci including Staphylococcus saprophyticus
- Side effects:
Gastrointestinal upset
Pulmonary toxicity
Hemolytic anemia in G6PD deficiency
- Clinical role:
First-line
Trimethoprim-sulfamethoxazole
- Mechanism:
Inhibits sequential steps in bacterial folate synthesis, leading to bactericidal activity against common urinary pathogens including Staphylococcus saprophyticus
- Side effects:
Rash
Hyperkalemia
Bone marrow suppression
- Clinical role:
First-line
Fosfomycin
- Mechanism:
Inhibits bacterial cell wall synthesis by blocking enolpyruvyl transferase, effective as a single-dose treatment for uncomplicated urinary tract infections
- Side effects:
Diarrhea
Headache
Vaginitis
- Clinical role:
First-line
Non-pharmacological Treatments
Increase fluid intake to promote urinary flushing and reduce bacterial load
Urinate frequently and after sexual intercourse to help clear bacteria from the urinary tract
Maintain good perineal hygiene to prevent bacterial colonization
Prevention
Pharmacological Prevention
Low-dose prophylactic antibiotics such as nitrofurantoin or trimethoprim-sulfamethoxazole for recurrent infections
Postcoital antibiotic prophylaxis to reduce infection risk in sexually active women
Non-pharmacological Prevention
Increased fluid intake to promote urinary flushing
Urinate promptly after intercourse to reduce bacterial colonization
Avoid spermicides and diaphragms which increase UTI risk
Good perineal hygiene wiping front to back to prevent bacterial spread
Outcome & Complications
Complications
Ascending infection leading to pyelonephritis if untreated
Recurrent urinary tract infections causing chronic symptoms
Urosepsis in severe or untreated cases
Renal scarring from repeated infections
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Urinary Tract Infection (Staphylococcus saprophyticus) versus Escherichia coli Urinary Tract Infection
Urinary Tract Infection (Staphylococcus saprophyticus) | Escherichia coli Urinary Tract Infection |
|---|---|
Gram-positive, novobiocin-resistant cocci causing UTIs | Gram-negative rod commonly causing UTIs |
Predominantly affects sexually active young women | More common in all age groups, especially in women with urinary catheterization or anatomical abnormalities |
Often resistant to nitrofurantoin; responds to fluoroquinolones or TMP-SMX | Typically sensitive to nitrofurantoin and trimethoprim-sulfamethoxazole |
Urinary Tract Infection (Staphylococcus saprophyticus) versus Candida Urinary Tract Infection
Urinary Tract Infection (Staphylococcus saprophyticus) | Candida Urinary Tract Infection |
|---|---|
Gram-positive cocci identified on urine culture | Yeast identified on urine microscopy and culture |
Common in healthy, sexually active young women | Common in immunocompromised patients or those with indwelling catheters |
No fungal elements; presence of gram-positive cocci clusters | Presence of pseudohyphae or budding yeast on microscopy |
Urinary Tract Infection (Staphylococcus saprophyticus) versus Acute Pyelonephritis
Urinary Tract Infection (Staphylococcus saprophyticus) | Acute Pyelonephritis |
|---|---|
Lower urinary tract symptoms without systemic signs | Fever, flank pain, and systemic symptoms with upper urinary tract involvement |
Normal renal imaging; infection localized to bladder or urethra | Renal ultrasound or CT showing renal enlargement or abscess |
Urine positive for leukocyte esterase and nitrites; blood cultures usually negative | Elevated white blood cell count with left shift and positive blood cultures possible |
Urinary Tract Infection (Staphylococcus saprophyticus) versus Interstitial Cystitis (Painful Bladder Syndrome)
Urinary Tract Infection (Staphylococcus saprophyticus) | Interstitial Cystitis (Painful Bladder Syndrome) |
|---|---|
Acute onset of dysuria and frequency with positive urine culture | Chronic pelvic pain with urinary frequency and urgency without infection |
Positive urine culture for bacteria | Sterile urine with no bacterial growth |
Improves with appropriate antibiotic therapy | No improvement with antibiotics; responds to bladder instillations or pain management |
Urinary Tract Infection (Staphylococcus saprophyticus) versus Urethritis due to Neisseria gonorrhoeae
Urinary Tract Infection (Staphylococcus saprophyticus) | Urethritis due to Neisseria gonorrhoeae |
|---|---|
Gram-positive cocci in clusters on urine culture | Gram-negative diplococci on urethral swab |
Sexually active young women without specific high-risk exposure | History of unprotected sexual contact with high-risk partner |
Negative NAAT for gonorrhea; positive urine culture for gram-positive cocci | Positive nucleic acid amplification test (NAAT) for gonorrhea |